Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Revenue Anticipated To Reach $7 Billion By 2030 With 18.1% CAGR
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market During The 2026–2030 Period?
The market for artificial intelligence (AI) in in vitro diagnostics (IVD) has experienced substantial growth recently. This market is projected to expand from $3.04 billion in 2025 to reach $3.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. Factors contributing to its historical expansion include a heightened need for precise diagnostic methods, the development of laboratory infrastructure, the growing incidence of chronic ailments, the integration of digital diagnostic instruments, and breakthroughs in biomarker research.
The market for artificial intelligence (ai) in in vitro diagnostics (ivd) is projected to experience substantial expansion over the coming years. This market is anticipated to reach $7.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This anticipated growth is driven by factors such as the proliferation of cloud-based diagnostic platforms, the incorporation of AI with genomics, advancements in point-of-care AI diagnostics, increased funding in personalized medicine, and a rising need for swift and economical testing solutions. Key trends expected during this period involve AI-powered laboratory automation, diagnostic tools for predicting diseases, interpretation of tests based on data, continued adoption of cloud-based diagnostic platforms, and individualized patient profiling.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp
What Market Drivers Are Helping Shape The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Expansion?
The increasing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market in the future. Personalized medicine defines a healthcare method that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. The rise of personalized medicine is fueled by progress in genomic data and sequencing technologies, which enable more accurate, targeted, and effective treatments tailored to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) assists personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, thereby enabling precise, timely, and tailored treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also included seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is powering the growth of the artificial intelligence (AI) in in vitro diagnostics (IVD) market.
What Are The Major Segment Categories Within The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The artificial intelligence (ai) in in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers
Subsegments:
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education
What Trends Are Influencing The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Outlook?
Leading companies within the artificial intelligence (AI) in in vitro diagnostics (IVD) market are prioritizing the creation of advanced solutions, including CE-IVDR-certified transparent AI platforms, with the goal of improving diagnostic precision, streamlining operational processes, and supporting individualized patient treatment. A CE-IVDR-certified transparent AI platform refers to an AI system for in vitro diagnostics that adheres to EU regulatory standards and delivers clear, auditable, and easily understandable decision-making. As an illustration, in May 2025, Diagnostics.ai, a diagnostic testing firm based in the UK, unveiled PCR.AI, an intelligent solution aimed at expediting and enhancing PCR diagnostics. This system automates and accelerates the interpretation of real-time PCR diagnostics with an accuracy exceeding 99.9%. It ensures transparency by explicitly detailing how each result is reached, thus securing regulatory compliance and elevating clinical confidence. This development markedly boosts laboratory efficiency, reduces inaccuracies, and facilitates uninterrupted regulatory adherence for molecular diagnostics.
Which Companies Form The Competitive Landscape Of The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating in the artificial intelligence (ai) in in vitro diagnostics (ivd) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, Aiforia Technologies Oyj
Access The Complete Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report:
Which Region Contributes The Most To The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28120&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
Artificial Intelligence In The Diagnostic Market Report 2026
Ai In Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Ai In Medical Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
